Hemogenyx Pharmaceuticals launches Phase I AML trial for HG-CT-1 CAR-T therapy

Hemogenyx Pharmaceuticals plc (LSE: HEMO), a leading biopharmaceutical company, has taken a significant step forward in the fight against acute myeloid leukemia (AML) by initiating ... Read More